Review



vi chicken egg albumin peptide ova323 339 invivogen vac isq  (InvivoGen)


Bioz Verified Symbol InvivoGen is a verified supplier
Bioz Manufacturer Symbol InvivoGen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    InvivoGen vi chicken egg albumin peptide ova323 339 invivogen vac isq
    Vi Chicken Egg Albumin Peptide Ova323 339 Invivogen Vac Isq, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 324 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ova+peptide/pm42288483-1102-40-46?v=InvivoGen
    Average 97 stars, based on 324 article reviews
    vi chicken egg albumin peptide ova323 339 invivogen vac isq - by Bioz Stars, 2026-08
    97/100 stars

    Images



    Similar Products

    96
    MedChemExpress ova peptide
    Ova Peptide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ova+peptide/custom%40hy-p1489%4042448134?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    ova peptide - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    97
    InvivoGen vi chicken egg albumin peptide ova323 339 invivogen vac isq
    Vi Chicken Egg Albumin Peptide Ova323 339 Invivogen Vac Isq, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ova+peptide/pm42288483-1102-40-46?v=InvivoGen
    Average 97 stars, based on 1 article reviews
    vi chicken egg albumin peptide ova323 339 invivogen vac isq - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    97
    InvivoGen ova peptide
    In this figure, CD53 + and CD53 − HSPCs were sorted on the basis of CD53 surface expression. ( A ) Representative histogram plot of splenic HSCs from CMO mice. The x axis indicates MHCII levels in CD53 − and CD53 + HSCs. Gray peak indicates signal for fluorescence minus one (FMO). ( B ) Frequency of MHCII + in CD53 − and CD53 + MPP and HSC from CMO BM, spleen, and paw. The y axes indicate percentage of MHCII + cells. ( C ) Schematic representation of coculture experiments. ( D ) Representative histogram plot of T cell proliferation after 4 days in coculture with DCs (T DC ; green), CD53 + HSPCs (T CD53+ ; blue), or CD53 − HSPCs (T CD53− ; gray) in the presence of ovalbumin 247-264 peptide <t>(OVA).</t> The negative control (dashed line) represents naïve CD4 + OTII T cells and OVA without APCs. The x axis indicates levels of Cell proliferation dye (CPD). ( E ) Percentage of proliferated CD4 + OTII T cells after 4 days of coculture with CD53 − HSPCs (gray), CD53 + HSPCs (blue), and DCs (green) in the presence of OVA. ( F ) Percentage of anergic CD4 + OTII T cells after 4 days of coculture with CD53 − HSPCs (gray), CD53 + HSPCs (blue), and DCs (green) in the presence of OVA. ( G ) Frequency of viable CD4 + OTII T cells after 4 days of coculture with indicated cells in the presence of OVA. The y axis indicates percentage of viable CD4 + OTII cells. ( H ) Number of OTII T reg cells after 4 days of coculture with the distinct cells types and in the presence of OVA. ( I ) Frequency of c-Kit + HSPCs after 4 days of coculture with naïve CD4 + OTII cells. First two columns represent negative <t>control</t> <t>cocultures</t> containing HSPCs and naïve CD4 + OTII cells without OVA. The other columns represent cocultures containing HSPCs, naïve CD4 + OTII cells, and OVA. HSPCs were CD53 − (gray) or CD53 + (blue). Mice used were 16- to 25-week-old male and female mice. * P < 0.05; ** P < 0.01; *** P < 0.001; and **** P < 0.0001; n.s.= not significant.
    Ova Peptide, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ova+peptide/pmc13148345-342-0-4?v=InvivoGen
    Average 97 stars, based on 1 article reviews
    ova peptide - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    96
    MedChemExpress ova257 264 peptide siinfekl
    In this figure, CD53 + and CD53 − HSPCs were sorted on the basis of CD53 surface expression. ( A ) Representative histogram plot of splenic HSCs from CMO mice. The x axis indicates MHCII levels in CD53 − and CD53 + HSCs. Gray peak indicates signal for fluorescence minus one (FMO). ( B ) Frequency of MHCII + in CD53 − and CD53 + MPP and HSC from CMO BM, spleen, and paw. The y axes indicate percentage of MHCII + cells. ( C ) Schematic representation of coculture experiments. ( D ) Representative histogram plot of T cell proliferation after 4 days in coculture with DCs (T DC ; green), CD53 + HSPCs (T CD53+ ; blue), or CD53 − HSPCs (T CD53− ; gray) in the presence of ovalbumin 247-264 peptide <t>(OVA).</t> The negative control (dashed line) represents naïve CD4 + OTII T cells and OVA without APCs. The x axis indicates levels of Cell proliferation dye (CPD). ( E ) Percentage of proliferated CD4 + OTII T cells after 4 days of coculture with CD53 − HSPCs (gray), CD53 + HSPCs (blue), and DCs (green) in the presence of OVA. ( F ) Percentage of anergic CD4 + OTII T cells after 4 days of coculture with CD53 − HSPCs (gray), CD53 + HSPCs (blue), and DCs (green) in the presence of OVA. ( G ) Frequency of viable CD4 + OTII T cells after 4 days of coculture with indicated cells in the presence of OVA. The y axis indicates percentage of viable CD4 + OTII cells. ( H ) Number of OTII T reg cells after 4 days of coculture with the distinct cells types and in the presence of OVA. ( I ) Frequency of c-Kit + HSPCs after 4 days of coculture with naïve CD4 + OTII cells. First two columns represent negative <t>control</t> <t>cocultures</t> containing HSPCs and naïve CD4 + OTII cells without OVA. The other columns represent cocultures containing HSPCs, naïve CD4 + OTII cells, and OVA. HSPCs were CD53 − (gray) or CD53 + (blue). Mice used were 16- to 25-week-old male and female mice. * P < 0.05; ** P < 0.01; *** P < 0.001; and **** P < 0.0001; n.s.= not significant.
    Ova257 264 Peptide Siinfekl, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ova+peptide/pm42102817-365-8-11?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    ova257 264 peptide siinfekl - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    MedChemExpress siinfekl peptide
    Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , <t>e</t> <t>BMDMs</t> from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated with <t>SIINFEKL,</t> then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells from OT-1 mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001
    Siinfekl Peptide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ova+peptide/pmc13121634-607-9-11?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    siinfekl peptide - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    MedChemExpress tcm
    Cohort and in vitro studies reveal the role of GPR34 in macrophages. a Volcano plot showing differentially expressed genes between responder group and non-responder group from the macrophage subclusters of scRNA sequencing data. The horizontal dashed line represents the P -value cutoff ( P < 10⁻⁵⁰), and the vertical dashed line represents the log 2 FC cutoff (-1 or 1). FC fold change, sig significance, R Responder, NR Non-responder. b , c UMAP plot showing the expression of GPR34 in all cells ( b ) and macrophages ( c ). Mac: Macrophage, cl cluster. d Representative mIF staining images (100x) of surgical specimens from responders and non-responders in the clinical trial ( n = 26). Navy: GPR34, Magenta: CD68, Red: CD8, Green: Tim-3, Yellow: CK19, Blue: DAPI. White arrowheads: Tim-3 + CD8 + exhausted T cells (Tex); White arrows: GPR34 + CD68 + macrophages. White scale bar = 100 μm. e Bar plot comparing the proportion of CD68 + macrophages (top) and the proportion of GPR34 + cells among CD68 + macrophages (bottom) between responders and non-responders. Two-tailed unpaired t-test. Data are presented by mean ± SD. * P < 0.05. f Bar plot comparing the proportion of CD8 + T cells (top) and the proportion of Tim-3 + cells among CD8 + T cells (bottom) between responders and non-responders. Two-tailed unpaired t-test. Data are presented by mean ± SD. g Representative mIF staining images (200x) of surgical specimens from clinical trial patients ( n = 26). Navy: GPR34, Magenta: CD68, Red: MPO, Green: CD3, Dark yellow: CD20, Yellow: CK19, Blue: DAPI. White scale bar = 50 μm. h Representative mIF staining images (200x) of clinical trial patient surgical specimens ( n = 26). Navy: GPR34, Magenta: CD68, Red: α-SMA, Green: CD31, Dark yellow: CD117, Yellow: CD56, Blue: DAPI. White scale bar = 50 μm. i Bar plots showing the ratio of GPR34 + cells in different cell types ( n = 26). One-way ANOVA with Dunnett’s test was used to compare other cell types versus macrophages. Data are presented by mean ± SD. j Bar plots showing the ratio of GPR34 + cells in different cell types ( n = 26) examined by flow cytometry. One-way ANOVA with Dunnett’s test was used to compare other cell types versus macrophages. Data are presented by mean ± SD. k , l Kaplan-Meier curves for overall survival (OS) and Recurrence-free survival (RFS) in the prospective cohort ( k ) and retrospective cohort ( l ), comparing prognosis between groups with high versus low infiltration of GPR34 + macrophages. The cutoff for the proportion of GPR34 + cells among CD68 + cells were dichotomized using a 20% . Log-rank test was used for comparison. m Flow cytometry analysis of GPR34 + cells in tumor tissue versus adjacent non-tumorous tissue from prospective cohort patients ( n = 42). Scatter plot shows the paired infiltration proportion of GPR34 + cells in tumor and normal tissue from the same patient . Two-tailed paired t -test was used. n Flow cytometry analysis of GPR34 + cells in tumor tissue from prospective cohort patients ( n = 42). Bar plots show the infiltration proportions of CD45 + cells, CD8 + T cells, Tim-3 + PD-1 + T cells, MRC1 + macrophages, and MHC-I + macrophages in the low GPR34 ( ≤ 20%) versus high GPR34 ( > 20%) groups. Two-tailed unpaired t-test. Data are presented by mean ± SD. o BMDMs from C57BL/6 mice were cultured until day <t>5,</t> <t>stimulated</t> with KPC cell <t>TCM</t> for 12 h, followed by treatment with Surufatinib (4 nM) or CSF-1R inhibitor (PLX3397, 20 nM) for 24 h, then analyzed by flow cytometry ( n = 3). Bar plot compares the gMFI of GPR34 among groups. One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001
    Tcm, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ova+peptide/pmc13121634-612-45-41?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    tcm - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    MedChemExpress bmdms
    Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e <t>BMDMs</t> from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated <t>with</t> <t>SIINFEKL,</t> then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells from OT-1 mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001
    Bmdms, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ova+peptide/pmc13121634-607-3-11?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    bmdms - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    98
    InvivoGen ova 323-339
    Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e <t>BMDMs</t> from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated <t>with</t> <t>SIINFEKL,</t> then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells from OT-1 mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001
    Ova 323 339, supplied by InvivoGen, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ova+peptide/custom%40vac-isq%4042003370?v=InvivoGen
    Average 98 stars, based on 1 article reviews
    ova 323-339 - by Bioz Stars, 2026-08
    98/100 stars
      Buy from Supplier

    97
    InvivoGen ovalbumin peptide
    Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e <t>BMDMs</t> from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated <t>with</t> <t>SIINFEKL,</t> then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells from OT-1 mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001
    Ovalbumin Peptide, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ova+peptide/pmc13072669-190-12-15?v=InvivoGen
    Average 97 stars, based on 1 article reviews
    ovalbumin peptide - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    Image Search Results


    In this figure, CD53 + and CD53 − HSPCs were sorted on the basis of CD53 surface expression. ( A ) Representative histogram plot of splenic HSCs from CMO mice. The x axis indicates MHCII levels in CD53 − and CD53 + HSCs. Gray peak indicates signal for fluorescence minus one (FMO). ( B ) Frequency of MHCII + in CD53 − and CD53 + MPP and HSC from CMO BM, spleen, and paw. The y axes indicate percentage of MHCII + cells. ( C ) Schematic representation of coculture experiments. ( D ) Representative histogram plot of T cell proliferation after 4 days in coculture with DCs (T DC ; green), CD53 + HSPCs (T CD53+ ; blue), or CD53 − HSPCs (T CD53− ; gray) in the presence of ovalbumin 247-264 peptide (OVA). The negative control (dashed line) represents naïve CD4 + OTII T cells and OVA without APCs. The x axis indicates levels of Cell proliferation dye (CPD). ( E ) Percentage of proliferated CD4 + OTII T cells after 4 days of coculture with CD53 − HSPCs (gray), CD53 + HSPCs (blue), and DCs (green) in the presence of OVA. ( F ) Percentage of anergic CD4 + OTII T cells after 4 days of coculture with CD53 − HSPCs (gray), CD53 + HSPCs (blue), and DCs (green) in the presence of OVA. ( G ) Frequency of viable CD4 + OTII T cells after 4 days of coculture with indicated cells in the presence of OVA. The y axis indicates percentage of viable CD4 + OTII cells. ( H ) Number of OTII T reg cells after 4 days of coculture with the distinct cells types and in the presence of OVA. ( I ) Frequency of c-Kit + HSPCs after 4 days of coculture with naïve CD4 + OTII cells. First two columns represent negative control cocultures containing HSPCs and naïve CD4 + OTII cells without OVA. The other columns represent cocultures containing HSPCs, naïve CD4 + OTII cells, and OVA. HSPCs were CD53 − (gray) or CD53 + (blue). Mice used were 16- to 25-week-old male and female mice. * P < 0.05; ** P < 0.01; *** P < 0.001; and **** P < 0.0001; n.s.= not significant.

    Journal: Science Advances

    Article Title: HSPCs and T reg cells cooperate to preserve extramedullary hematopoiesis under chronic inflammation

    doi: 10.1126/sciadv.adv9351

    Figure Lengend Snippet: In this figure, CD53 + and CD53 − HSPCs were sorted on the basis of CD53 surface expression. ( A ) Representative histogram plot of splenic HSCs from CMO mice. The x axis indicates MHCII levels in CD53 − and CD53 + HSCs. Gray peak indicates signal for fluorescence minus one (FMO). ( B ) Frequency of MHCII + in CD53 − and CD53 + MPP and HSC from CMO BM, spleen, and paw. The y axes indicate percentage of MHCII + cells. ( C ) Schematic representation of coculture experiments. ( D ) Representative histogram plot of T cell proliferation after 4 days in coculture with DCs (T DC ; green), CD53 + HSPCs (T CD53+ ; blue), or CD53 − HSPCs (T CD53− ; gray) in the presence of ovalbumin 247-264 peptide (OVA). The negative control (dashed line) represents naïve CD4 + OTII T cells and OVA without APCs. The x axis indicates levels of Cell proliferation dye (CPD). ( E ) Percentage of proliferated CD4 + OTII T cells after 4 days of coculture with CD53 − HSPCs (gray), CD53 + HSPCs (blue), and DCs (green) in the presence of OVA. ( F ) Percentage of anergic CD4 + OTII T cells after 4 days of coculture with CD53 − HSPCs (gray), CD53 + HSPCs (blue), and DCs (green) in the presence of OVA. ( G ) Frequency of viable CD4 + OTII T cells after 4 days of coculture with indicated cells in the presence of OVA. The y axis indicates percentage of viable CD4 + OTII cells. ( H ) Number of OTII T reg cells after 4 days of coculture with the distinct cells types and in the presence of OVA. ( I ) Frequency of c-Kit + HSPCs after 4 days of coculture with naïve CD4 + OTII cells. First two columns represent negative control cocultures containing HSPCs and naïve CD4 + OTII cells without OVA. The other columns represent cocultures containing HSPCs, naïve CD4 + OTII cells, and OVA. HSPCs were CD53 − (gray) or CD53 + (blue). Mice used were 16- to 25-week-old male and female mice. * P < 0.05; ** P < 0.01; *** P < 0.001; and **** P < 0.0001; n.s.= not significant.

    Article Snippet: OVA peptide (OVA 323-339, InvivoGen) was introduced to stimulate the cocultures.

    Techniques: Expressing, Fluorescence, Negative Control

    Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated with SIINFEKL, then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells from OT-1 mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Journal: Signal Transduction and Targeted Therapy

    Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer

    doi: 10.1038/s41392-026-02641-4

    Figure Lengend Snippet: Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated with SIINFEKL, then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells from OT-1 mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Article Snippet: For antigen-specific assays, BMDMs were pulsed with 1 μg/mL SIINFEKL peptide (MCE, HY-P1489) for 2 hours.

    Techniques: Biomarker Discovery, Co-Culture Assay, Injection, Imaging, Cell Culture, Isolation, Flow Cytometry, Expressing, Functional Assay, Two Tailed Test, Immunopeptidomics, Sequencing, Enzyme-linked Immunosorbent Assay, Transfection, Control

    Macrophage efferocytosis function influences antigen presentation ability through MHC-I. a BMDMs from C57BL/6 mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 hours, then analyzed by flow cytometry for GFP uptake. Bar plot shows gMFI of GFP in BMDMs treated with MerTK inhibitor vs control ( n = 3). One-way ANOVA with Dunnett’s test compared MerTKi groups to control. Data are presented by mean ± SD. b BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP cells for 12 hours, treated with MerTK inhibitor, then co-cultured with CD8 + T cells from OT1 mice for 24 hours. Flow cytometry detected MHC-I, SIINFEKL loading, CD80, CD86 on BMDMs. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. c Flow cytometry detection of Tetramer + , PD-1 + , Tim-3 + , and GZMB + cells after co-culture of BMDMs with OT1 CD8 + T cells. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. d Apoptotic KPC cells induced by chemotherapy and labeled with Caspase3/7 green were co-cultured with BMDMs. Phagolysosome formation was detected using pHrodo red. Representative fluorescence microscopy images (1000x) show differences between MerTK inhibitor and control groups ( n = 6). Green: Caspase3/7, Red: pHrodo, Blue: DAPI. White scale bar= 20 μm. e Bar plots show total pHrodo fluorescence intensity (left) and the number of Caspase3/7 + pHrodo + vesicles per cell (right) in BMDMs after incubation with apoptotic cells ( n = 6). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. f Flow cytometry analysis of pHrodo gMFI in BMDMs after incubation with apoptotic cells. Bar plot shows pHrodo gMFI levels between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. g Violin-box plots of lysosome-associated gene transcript expression in macrophage subpopulations from scRNA sequencing data. Solid lines represent medians and quartiles. One-way ANOVA with Kruskal-Wallis H test compared groups (Mac_cl1 as reference). h , i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours. After removing apoptotic cells, RNA was extracted for qPCR. Bar plots show transcript differences between Gpr34 +/+ and Gpr34 −/− BMDMs ( h ) efferocytosis receptors, ( i ) lysosome-related/transcription factors, ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-incubated with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours and analyzed by flow cytometry. Bar plot shows differences in MHC-I protein levels between knockdown and control groups ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. k BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with lysosomal inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Bar plot shows pHrodo gMFI in macrophages from flow cytometry, comparing lysosomal inhibitor group vs control. One-way ANOVA with Dunnett’s test was used . Data are presented by mean ± SD. l , m Flow cytometry detection of macrophage antigen presentation function ( l ) and CD8 + T cell specific killing capacity ( m ) in the BMDM-OT1 CD8 + T cell co-culture system. Bar plots show differences between lysosomal inhibitor and control groups. One-way ANOVA with Dunnett ’ s test was used. Data are presented by mean ± SD. n BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM, MerTK inhibitor/Lysosome inhibitor and chemotherapy-induced apoptotic KPC cells for 12 hours. Bar plot shows differences in MHC-I protein levels between different groups detected by flow cytometry ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. o –q BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, transiently transfected with Cxcl16 siRNA, co-incubated with TCM, LysoPS and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with MerTK inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Flow cytometry detected CD8 + T cell specific killing function (o ), cytotoxic function ( p ), and exhaustion levels ( q ). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Journal: Signal Transduction and Targeted Therapy

    Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer

    doi: 10.1038/s41392-026-02641-4

    Figure Lengend Snippet: Macrophage efferocytosis function influences antigen presentation ability through MHC-I. a BMDMs from C57BL/6 mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 hours, then analyzed by flow cytometry for GFP uptake. Bar plot shows gMFI of GFP in BMDMs treated with MerTK inhibitor vs control ( n = 3). One-way ANOVA with Dunnett’s test compared MerTKi groups to control. Data are presented by mean ± SD. b BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP cells for 12 hours, treated with MerTK inhibitor, then co-cultured with CD8 + T cells from OT1 mice for 24 hours. Flow cytometry detected MHC-I, SIINFEKL loading, CD80, CD86 on BMDMs. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. c Flow cytometry detection of Tetramer + , PD-1 + , Tim-3 + , and GZMB + cells after co-culture of BMDMs with OT1 CD8 + T cells. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. d Apoptotic KPC cells induced by chemotherapy and labeled with Caspase3/7 green were co-cultured with BMDMs. Phagolysosome formation was detected using pHrodo red. Representative fluorescence microscopy images (1000x) show differences between MerTK inhibitor and control groups ( n = 6). Green: Caspase3/7, Red: pHrodo, Blue: DAPI. White scale bar= 20 μm. e Bar plots show total pHrodo fluorescence intensity (left) and the number of Caspase3/7 + pHrodo + vesicles per cell (right) in BMDMs after incubation with apoptotic cells ( n = 6). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. f Flow cytometry analysis of pHrodo gMFI in BMDMs after incubation with apoptotic cells. Bar plot shows pHrodo gMFI levels between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. g Violin-box plots of lysosome-associated gene transcript expression in macrophage subpopulations from scRNA sequencing data. Solid lines represent medians and quartiles. One-way ANOVA with Kruskal-Wallis H test compared groups (Mac_cl1 as reference). h , i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours. After removing apoptotic cells, RNA was extracted for qPCR. Bar plots show transcript differences between Gpr34 +/+ and Gpr34 −/− BMDMs ( h ) efferocytosis receptors, ( i ) lysosome-related/transcription factors, ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-incubated with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours and analyzed by flow cytometry. Bar plot shows differences in MHC-I protein levels between knockdown and control groups ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. k BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with lysosomal inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Bar plot shows pHrodo gMFI in macrophages from flow cytometry, comparing lysosomal inhibitor group vs control. One-way ANOVA with Dunnett’s test was used . Data are presented by mean ± SD. l , m Flow cytometry detection of macrophage antigen presentation function ( l ) and CD8 + T cell specific killing capacity ( m ) in the BMDM-OT1 CD8 + T cell co-culture system. Bar plots show differences between lysosomal inhibitor and control groups. One-way ANOVA with Dunnett ’ s test was used. Data are presented by mean ± SD. n BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM, MerTK inhibitor/Lysosome inhibitor and chemotherapy-induced apoptotic KPC cells for 12 hours. Bar plot shows differences in MHC-I protein levels between different groups detected by flow cytometry ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. o –q BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, transiently transfected with Cxcl16 siRNA, co-incubated with TCM, LysoPS and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with MerTK inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Flow cytometry detected CD8 + T cell specific killing function (o ), cytotoxic function ( p ), and exhaustion levels ( q ). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Article Snippet: For antigen-specific assays, BMDMs were pulsed with 1 μg/mL SIINFEKL peptide (MCE, HY-P1489) for 2 hours.

    Techniques: Immunopeptidomics, Cell Culture, Flow Cytometry, Control, Incubation, Co-Culture Assay, Labeling, Fluorescence, Microscopy, Expressing, Sequencing, Two Tailed Test, Transfection, Knockdown

    Cohort and in vitro studies reveal the role of GPR34 in macrophages. a Volcano plot showing differentially expressed genes between responder group and non-responder group from the macrophage subclusters of scRNA sequencing data. The horizontal dashed line represents the P -value cutoff ( P < 10⁻⁵⁰), and the vertical dashed line represents the log 2 FC cutoff (-1 or 1). FC fold change, sig significance, R Responder, NR Non-responder. b , c UMAP plot showing the expression of GPR34 in all cells ( b ) and macrophages ( c ). Mac: Macrophage, cl cluster. d Representative mIF staining images (100x) of surgical specimens from responders and non-responders in the clinical trial ( n = 26). Navy: GPR34, Magenta: CD68, Red: CD8, Green: Tim-3, Yellow: CK19, Blue: DAPI. White arrowheads: Tim-3 + CD8 + exhausted T cells (Tex); White arrows: GPR34 + CD68 + macrophages. White scale bar = 100 μm. e Bar plot comparing the proportion of CD68 + macrophages (top) and the proportion of GPR34 + cells among CD68 + macrophages (bottom) between responders and non-responders. Two-tailed unpaired t-test. Data are presented by mean ± SD. * P < 0.05. f Bar plot comparing the proportion of CD8 + T cells (top) and the proportion of Tim-3 + cells among CD8 + T cells (bottom) between responders and non-responders. Two-tailed unpaired t-test. Data are presented by mean ± SD. g Representative mIF staining images (200x) of surgical specimens from clinical trial patients ( n = 26). Navy: GPR34, Magenta: CD68, Red: MPO, Green: CD3, Dark yellow: CD20, Yellow: CK19, Blue: DAPI. White scale bar = 50 μm. h Representative mIF staining images (200x) of clinical trial patient surgical specimens ( n = 26). Navy: GPR34, Magenta: CD68, Red: α-SMA, Green: CD31, Dark yellow: CD117, Yellow: CD56, Blue: DAPI. White scale bar = 50 μm. i Bar plots showing the ratio of GPR34 + cells in different cell types ( n = 26). One-way ANOVA with Dunnett’s test was used to compare other cell types versus macrophages. Data are presented by mean ± SD. j Bar plots showing the ratio of GPR34 + cells in different cell types ( n = 26) examined by flow cytometry. One-way ANOVA with Dunnett’s test was used to compare other cell types versus macrophages. Data are presented by mean ± SD. k , l Kaplan-Meier curves for overall survival (OS) and Recurrence-free survival (RFS) in the prospective cohort ( k ) and retrospective cohort ( l ), comparing prognosis between groups with high versus low infiltration of GPR34 + macrophages. The cutoff for the proportion of GPR34 + cells among CD68 + cells were dichotomized using a 20% . Log-rank test was used for comparison. m Flow cytometry analysis of GPR34 + cells in tumor tissue versus adjacent non-tumorous tissue from prospective cohort patients ( n = 42). Scatter plot shows the paired infiltration proportion of GPR34 + cells in tumor and normal tissue from the same patient . Two-tailed paired t -test was used. n Flow cytometry analysis of GPR34 + cells in tumor tissue from prospective cohort patients ( n = 42). Bar plots show the infiltration proportions of CD45 + cells, CD8 + T cells, Tim-3 + PD-1 + T cells, MRC1 + macrophages, and MHC-I + macrophages in the low GPR34 ( ≤ 20%) versus high GPR34 ( > 20%) groups. Two-tailed unpaired t-test. Data are presented by mean ± SD. o BMDMs from C57BL/6 mice were cultured until day 5, stimulated with KPC cell TCM for 12 h, followed by treatment with Surufatinib (4 nM) or CSF-1R inhibitor (PLX3397, 20 nM) for 24 h, then analyzed by flow cytometry ( n = 3). Bar plot compares the gMFI of GPR34 among groups. One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001

    Journal: Signal Transduction and Targeted Therapy

    Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer

    doi: 10.1038/s41392-026-02641-4

    Figure Lengend Snippet: Cohort and in vitro studies reveal the role of GPR34 in macrophages. a Volcano plot showing differentially expressed genes between responder group and non-responder group from the macrophage subclusters of scRNA sequencing data. The horizontal dashed line represents the P -value cutoff ( P < 10⁻⁵⁰), and the vertical dashed line represents the log 2 FC cutoff (-1 or 1). FC fold change, sig significance, R Responder, NR Non-responder. b , c UMAP plot showing the expression of GPR34 in all cells ( b ) and macrophages ( c ). Mac: Macrophage, cl cluster. d Representative mIF staining images (100x) of surgical specimens from responders and non-responders in the clinical trial ( n = 26). Navy: GPR34, Magenta: CD68, Red: CD8, Green: Tim-3, Yellow: CK19, Blue: DAPI. White arrowheads: Tim-3 + CD8 + exhausted T cells (Tex); White arrows: GPR34 + CD68 + macrophages. White scale bar = 100 μm. e Bar plot comparing the proportion of CD68 + macrophages (top) and the proportion of GPR34 + cells among CD68 + macrophages (bottom) between responders and non-responders. Two-tailed unpaired t-test. Data are presented by mean ± SD. * P < 0.05. f Bar plot comparing the proportion of CD8 + T cells (top) and the proportion of Tim-3 + cells among CD8 + T cells (bottom) between responders and non-responders. Two-tailed unpaired t-test. Data are presented by mean ± SD. g Representative mIF staining images (200x) of surgical specimens from clinical trial patients ( n = 26). Navy: GPR34, Magenta: CD68, Red: MPO, Green: CD3, Dark yellow: CD20, Yellow: CK19, Blue: DAPI. White scale bar = 50 μm. h Representative mIF staining images (200x) of clinical trial patient surgical specimens ( n = 26). Navy: GPR34, Magenta: CD68, Red: α-SMA, Green: CD31, Dark yellow: CD117, Yellow: CD56, Blue: DAPI. White scale bar = 50 μm. i Bar plots showing the ratio of GPR34 + cells in different cell types ( n = 26). One-way ANOVA with Dunnett’s test was used to compare other cell types versus macrophages. Data are presented by mean ± SD. j Bar plots showing the ratio of GPR34 + cells in different cell types ( n = 26) examined by flow cytometry. One-way ANOVA with Dunnett’s test was used to compare other cell types versus macrophages. Data are presented by mean ± SD. k , l Kaplan-Meier curves for overall survival (OS) and Recurrence-free survival (RFS) in the prospective cohort ( k ) and retrospective cohort ( l ), comparing prognosis between groups with high versus low infiltration of GPR34 + macrophages. The cutoff for the proportion of GPR34 + cells among CD68 + cells were dichotomized using a 20% . Log-rank test was used for comparison. m Flow cytometry analysis of GPR34 + cells in tumor tissue versus adjacent non-tumorous tissue from prospective cohort patients ( n = 42). Scatter plot shows the paired infiltration proportion of GPR34 + cells in tumor and normal tissue from the same patient . Two-tailed paired t -test was used. n Flow cytometry analysis of GPR34 + cells in tumor tissue from prospective cohort patients ( n = 42). Bar plots show the infiltration proportions of CD45 + cells, CD8 + T cells, Tim-3 + PD-1 + T cells, MRC1 + macrophages, and MHC-I + macrophages in the low GPR34 ( ≤ 20%) versus high GPR34 ( > 20%) groups. Two-tailed unpaired t-test. Data are presented by mean ± SD. o BMDMs from C57BL/6 mice were cultured until day 5, stimulated with KPC cell TCM for 12 h, followed by treatment with Surufatinib (4 nM) or CSF-1R inhibitor (PLX3397, 20 nM) for 24 h, then analyzed by flow cytometry ( n = 3). Bar plot compares the gMFI of GPR34 among groups. One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001

    Article Snippet: For BMDM and OT-1 CD8 + T cell co-culture, BMDMs from OT-1 mice (8 weeks) were isolated and cultured according to standard methods, and the stimulation reached No. At 5 days, BMDMs were stimulated with OVA peptide (257-264) (SIINFEKL, 1 μg/mL, MCE, HY-P1489) added to TCM for 24 h to induce antigen presentation.

    Techniques: In Vitro, Sequencing, Expressing, Staining, Two Tailed Test, Flow Cytometry, Comparison, Cell Culture

    Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated with SIINFEKL, then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells from OT-1 mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Journal: Signal Transduction and Targeted Therapy

    Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer

    doi: 10.1038/s41392-026-02641-4

    Figure Lengend Snippet: Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated with SIINFEKL, then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells from OT-1 mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Article Snippet: For BMDM and OT-1 CD8 + T cell co-culture, BMDMs from OT-1 mice (8 weeks) were isolated and cultured according to standard methods, and the stimulation reached No. At 5 days, BMDMs were stimulated with OVA peptide (257-264) (SIINFEKL, 1 μg/mL, MCE, HY-P1489) added to TCM for 24 h to induce antigen presentation.

    Techniques: Biomarker Discovery, Co-Culture Assay, Injection, Imaging, Cell Culture, Isolation, Flow Cytometry, Expressing, Functional Assay, Two Tailed Test, Immunopeptidomics, Sequencing, Enzyme-linked Immunosorbent Assay, Transfection, Control

    LysoPS-GPR34 modulates macrophage efferocytosis and inflammatory cytokine secretion. a , b BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. These were then co-cultured with CD8 + T cells for 24 hours. Flow cytometry detected GFP efferocytosis ( a ) and p-AKT levels ( b ) in BMDMs. Bar plots show differences among groups. One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. c BMDMs from Gpr34 +/+ and Gpr34 −/− mice were treated with LysoPS and co-cultured with CD8 + T cells. Flow cytometry detected MRC1, MHC-I on macrophages, and Tim-3, GZMB on CD8 + T cells. Bar plot shows gMFI differences among groups. One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. d , e BMDMs from C57BL/6 mice were treated with LysoPS and AKT inhibitor, then co-cultured with chemotherapy-induced apoptotic KPC-GFP cells for 12 h, followed by co-culture with CD8 + T cells for 24 h. Flow cytometry detected GFP uptake by BMDMs ( d ) and exhaustion/cytotoxicity levels of CD8 + T cells ( e ). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. f UMA P plot showing relative expression of efferocytosis-related genes from scRNA sequencing analysis. g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, co-cultured with TCM and either chemotherapy-induced apoptotic KPC-GFP cells or normal KPC-GFP cells for 12 h. After removing cells, RNA was extracted for qPCR. Bar plot compares transcript levels among groups. One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. h BMDMs from C57BL/6 mice were cultured until day 5, co-cultured with apoptotic KPC cells of negative control for 12 hours. RNA was extracted for qPCR. Bar plot compares transcript differences among groups. One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. i BMDMs from C57BL/6 mice were cultured until day 5, stimulated with TCM and LysoPS for 12 h. ELISA detected CXCL16 secretion in supernatant. Bar plot shows levels in LysoPS vs. control groups. Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001

    Journal: Signal Transduction and Targeted Therapy

    Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer

    doi: 10.1038/s41392-026-02641-4

    Figure Lengend Snippet: LysoPS-GPR34 modulates macrophage efferocytosis and inflammatory cytokine secretion. a , b BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. These were then co-cultured with CD8 + T cells for 24 hours. Flow cytometry detected GFP efferocytosis ( a ) and p-AKT levels ( b ) in BMDMs. Bar plots show differences among groups. One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. c BMDMs from Gpr34 +/+ and Gpr34 −/− mice were treated with LysoPS and co-cultured with CD8 + T cells. Flow cytometry detected MRC1, MHC-I on macrophages, and Tim-3, GZMB on CD8 + T cells. Bar plot shows gMFI differences among groups. One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. d , e BMDMs from C57BL/6 mice were treated with LysoPS and AKT inhibitor, then co-cultured with chemotherapy-induced apoptotic KPC-GFP cells for 12 h, followed by co-culture with CD8 + T cells for 24 h. Flow cytometry detected GFP uptake by BMDMs ( d ) and exhaustion/cytotoxicity levels of CD8 + T cells ( e ). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. f UMA P plot showing relative expression of efferocytosis-related genes from scRNA sequencing analysis. g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, co-cultured with TCM and either chemotherapy-induced apoptotic KPC-GFP cells or normal KPC-GFP cells for 12 h. After removing cells, RNA was extracted for qPCR. Bar plot compares transcript levels among groups. One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. h BMDMs from C57BL/6 mice were cultured until day 5, co-cultured with apoptotic KPC cells of negative control for 12 hours. RNA was extracted for qPCR. Bar plot compares transcript differences among groups. One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. i BMDMs from C57BL/6 mice were cultured until day 5, stimulated with TCM and LysoPS for 12 h. ELISA detected CXCL16 secretion in supernatant. Bar plot shows levels in LysoPS vs. control groups. Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001

    Article Snippet: For BMDM and OT-1 CD8 + T cell co-culture, BMDMs from OT-1 mice (8 weeks) were isolated and cultured according to standard methods, and the stimulation reached No. At 5 days, BMDMs were stimulated with OVA peptide (257-264) (SIINFEKL, 1 μg/mL, MCE, HY-P1489) added to TCM for 24 h to induce antigen presentation.

    Techniques: Cell Culture, Flow Cytometry, Co-Culture Assay, Expressing, Sequencing, Negative Control, Enzyme-linked Immunosorbent Assay, Control, Two Tailed Test

    Macrophage efferocytosis function influences antigen presentation ability through MHC-I. a BMDMs from C57BL/6 mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 hours, then analyzed by flow cytometry for GFP uptake. Bar plot shows gMFI of GFP in BMDMs treated with MerTK inhibitor vs control ( n = 3). One-way ANOVA with Dunnett’s test compared MerTKi groups to control. Data are presented by mean ± SD. b BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP cells for 12 hours, treated with MerTK inhibitor, then co-cultured with CD8 + T cells from OT1 mice for 24 hours. Flow cytometry detected MHC-I, SIINFEKL loading, CD80, CD86 on BMDMs. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. c Flow cytometry detection of Tetramer + , PD-1 + , Tim-3 + , and GZMB + cells after co-culture of BMDMs with OT1 CD8 + T cells. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. d Apoptotic KPC cells induced by chemotherapy and labeled with Caspase3/7 green were co-cultured with BMDMs. Phagolysosome formation was detected using pHrodo red. Representative fluorescence microscopy images (1000x) show differences between MerTK inhibitor and control groups ( n = 6). Green: Caspase3/7, Red: pHrodo, Blue: DAPI. White scale bar= 20 μm. e Bar plots show total pHrodo fluorescence intensity (left) and the number of Caspase3/7 + pHrodo + vesicles per cell (right) in BMDMs after incubation with apoptotic cells ( n = 6). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. f Flow cytometry analysis of pHrodo gMFI in BMDMs after incubation with apoptotic cells. Bar plot shows pHrodo gMFI levels between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. g Violin-box plots of lysosome-associated gene transcript expression in macrophage subpopulations from scRNA sequencing data. Solid lines represent medians and quartiles. One-way ANOVA with Kruskal-Wallis H test compared groups (Mac_cl1 as reference). h , i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours. After removing apoptotic cells, RNA was extracted for qPCR. Bar plots show transcript differences between Gpr34 +/+ and Gpr34 −/− BMDMs ( h ) efferocytosis receptors, ( i ) lysosome-related/transcription factors, ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-incubated with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours and analyzed by flow cytometry. Bar plot shows differences in MHC-I protein levels between knockdown and control groups ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. k BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with lysosomal inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Bar plot shows pHrodo gMFI in macrophages from flow cytometry, comparing lysosomal inhibitor group vs control. One-way ANOVA with Dunnett’s test was used . Data are presented by mean ± SD. l , m Flow cytometry detection of macrophage antigen presentation function ( l ) and CD8 + T cell specific killing capacity ( m ) in the BMDM-OT1 CD8 + T cell co-culture system. Bar plots show differences between lysosomal inhibitor and control groups. One-way ANOVA with Dunnett ’ s test was used. Data are presented by mean ± SD. n BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM, MerTK inhibitor/Lysosome inhibitor and chemotherapy-induced apoptotic KPC cells for 12 hours. Bar plot shows differences in MHC-I protein levels between different groups detected by flow cytometry ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. o –q BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, transiently transfected with Cxcl16 siRNA, co-incubated with TCM, LysoPS and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with MerTK inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Flow cytometry detected CD8 + T cell specific killing function (o ), cytotoxic function ( p ), and exhaustion levels ( q ). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Journal: Signal Transduction and Targeted Therapy

    Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer

    doi: 10.1038/s41392-026-02641-4

    Figure Lengend Snippet: Macrophage efferocytosis function influences antigen presentation ability through MHC-I. a BMDMs from C57BL/6 mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 hours, then analyzed by flow cytometry for GFP uptake. Bar plot shows gMFI of GFP in BMDMs treated with MerTK inhibitor vs control ( n = 3). One-way ANOVA with Dunnett’s test compared MerTKi groups to control. Data are presented by mean ± SD. b BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP cells for 12 hours, treated with MerTK inhibitor, then co-cultured with CD8 + T cells from OT1 mice for 24 hours. Flow cytometry detected MHC-I, SIINFEKL loading, CD80, CD86 on BMDMs. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. c Flow cytometry detection of Tetramer + , PD-1 + , Tim-3 + , and GZMB + cells after co-culture of BMDMs with OT1 CD8 + T cells. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. d Apoptotic KPC cells induced by chemotherapy and labeled with Caspase3/7 green were co-cultured with BMDMs. Phagolysosome formation was detected using pHrodo red. Representative fluorescence microscopy images (1000x) show differences between MerTK inhibitor and control groups ( n = 6). Green: Caspase3/7, Red: pHrodo, Blue: DAPI. White scale bar= 20 μm. e Bar plots show total pHrodo fluorescence intensity (left) and the number of Caspase3/7 + pHrodo + vesicles per cell (right) in BMDMs after incubation with apoptotic cells ( n = 6). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. f Flow cytometry analysis of pHrodo gMFI in BMDMs after incubation with apoptotic cells. Bar plot shows pHrodo gMFI levels between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. g Violin-box plots of lysosome-associated gene transcript expression in macrophage subpopulations from scRNA sequencing data. Solid lines represent medians and quartiles. One-way ANOVA with Kruskal-Wallis H test compared groups (Mac_cl1 as reference). h , i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours. After removing apoptotic cells, RNA was extracted for qPCR. Bar plots show transcript differences between Gpr34 +/+ and Gpr34 −/− BMDMs ( h ) efferocytosis receptors, ( i ) lysosome-related/transcription factors, ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-incubated with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours and analyzed by flow cytometry. Bar plot shows differences in MHC-I protein levels between knockdown and control groups ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. k BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with lysosomal inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Bar plot shows pHrodo gMFI in macrophages from flow cytometry, comparing lysosomal inhibitor group vs control. One-way ANOVA with Dunnett’s test was used . Data are presented by mean ± SD. l , m Flow cytometry detection of macrophage antigen presentation function ( l ) and CD8 + T cell specific killing capacity ( m ) in the BMDM-OT1 CD8 + T cell co-culture system. Bar plots show differences between lysosomal inhibitor and control groups. One-way ANOVA with Dunnett ’ s test was used. Data are presented by mean ± SD. n BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM, MerTK inhibitor/Lysosome inhibitor and chemotherapy-induced apoptotic KPC cells for 12 hours. Bar plot shows differences in MHC-I protein levels between different groups detected by flow cytometry ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. o –q BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, transiently transfected with Cxcl16 siRNA, co-incubated with TCM, LysoPS and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with MerTK inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Flow cytometry detected CD8 + T cell specific killing function (o ), cytotoxic function ( p ), and exhaustion levels ( q ). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Article Snippet: For BMDM and OT-1 CD8 + T cell co-culture, BMDMs from OT-1 mice (8 weeks) were isolated and cultured according to standard methods, and the stimulation reached No. At 5 days, BMDMs were stimulated with OVA peptide (257-264) (SIINFEKL, 1 μg/mL, MCE, HY-P1489) added to TCM for 24 h to induce antigen presentation.

    Techniques: Immunopeptidomics, Cell Culture, Flow Cytometry, Control, Incubation, Co-Culture Assay, Labeling, Fluorescence, Microscopy, Expressing, Sequencing, Two Tailed Test, Transfection, Knockdown

    Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated with SIINFEKL, then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells from OT-1 mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Journal: Signal Transduction and Targeted Therapy

    Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer

    doi: 10.1038/s41392-026-02641-4

    Figure Lengend Snippet: Validation of GPR34 function in macrophage and CD8 + T cell co-culture system. a Gpr34 flox/flox and Gpr34 Δ Lyz2 mice were treated with anti-CD8α or IgG, followed by orthotopic pancreatic injection of KPC-LUC cells. After tumor formation, chemotherapy was administered to simulate an injury signal. Tumor bioluminescence was dynamically monitored. Representative bioluminescence images show tumor growth in different groups ( n = 6). b Time-course curve of bioluminescence imaging for the KPC-LUC orthotopic model ( n = 6). Two-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance, *** P < 0.001. c Bar plot showing tumor weight on day 21 in the KPC-LUC orthotopic model ( n = 6). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. NS no significance. d , e BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then co-cultured with TCM and KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells for 24 hours . Flow cytometry analyzed the expression of functional molecules in BMDMs ( d ) and CD8 + T cells ( e ). Bar plots show levels in Gpr34 +/+ vs Gpr34 −/− groups ( n = 3). Two-tailed unpaired Student’s t test was used. Data are presented by mean ± SD. f , g BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, pre-stimulated with SIINFEKL, then cultured with TCM for 12 h, followed by co-culture with CD8 + T cells from OT-1 mice for 24 h. Flow cytometry detected T cell-specific killing function ( f ) and BMDM antigen presentation function ( g ). Bar plots show differences between Gpr34 +/+ and Gpr34 −/− groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. h Violin-box plots of cytokine transcript expression in macrophage clusters from scRNA sequencing data. White dot and solid lines in boxes represent medians and quartiles. Two-tailed Wilcoxon test. i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, then stimulated with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. qPCR detected Cxcl16 transcript levels. Bar plot compares Cxcl16 transcripts between groups ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j ELISA detection of cytokine secretion in supernatant from BMDMs stimulated with apoptotic KPC-GFP cells. Bar plot shows CXCL16 protein secretion levels from Gpr34 +/+ and Gpr34 −/− BMDMs ( n = 10). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. k , l BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-cultured with TCM, LysoPS and chemotherapy-induced apoptotic KPC-GFP cells for 12 h. BMDMs were then isolated and co-cultured with CD8 + T cells. Flow cytometry detected T cell exhaustion ( k ) and cytotoxicity levels ( l ) ( n = 3). One-way ANOVA with Dunnett’s test compared siRNA groups versus control. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Article Snippet: For antigen-specific assays, BMDMs were pulsed with 1 μg/mL SIINFEKL peptide (MCE, HY-P1489) for 2 hours.

    Techniques: Biomarker Discovery, Co-Culture Assay, Injection, Imaging, Cell Culture, Isolation, Flow Cytometry, Expressing, Functional Assay, Two Tailed Test, Immunopeptidomics, Sequencing, Enzyme-linked Immunosorbent Assay, Transfection, Control

    Macrophage efferocytosis function influences antigen presentation ability through MHC-I. a BMDMs from C57BL/6 mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 hours, then analyzed by flow cytometry for GFP uptake. Bar plot shows gMFI of GFP in BMDMs treated with MerTK inhibitor vs control ( n = 3). One-way ANOVA with Dunnett’s test compared MerTKi groups to control. Data are presented by mean ± SD. b BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP cells for 12 hours, treated with MerTK inhibitor, then co-cultured with CD8 + T cells from OT1 mice for 24 hours. Flow cytometry detected MHC-I, SIINFEKL loading, CD80, CD86 on BMDMs. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. c Flow cytometry detection of Tetramer + , PD-1 + , Tim-3 + , and GZMB + cells after co-culture of BMDMs with OT1 CD8 + T cells. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. d Apoptotic KPC cells induced by chemotherapy and labeled with Caspase3/7 green were co-cultured with BMDMs. Phagolysosome formation was detected using pHrodo red. Representative fluorescence microscopy images (1000x) show differences between MerTK inhibitor and control groups ( n = 6). Green: Caspase3/7, Red: pHrodo, Blue: DAPI. White scale bar= 20 μm. e Bar plots show total pHrodo fluorescence intensity (left) and the number of Caspase3/7 + pHrodo + vesicles per cell (right) in BMDMs after incubation with apoptotic cells ( n = 6). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. f Flow cytometry analysis of pHrodo gMFI in BMDMs after incubation with apoptotic cells. Bar plot shows pHrodo gMFI levels between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. g Violin-box plots of lysosome-associated gene transcript expression in macrophage subpopulations from scRNA sequencing data. Solid lines represent medians and quartiles. One-way ANOVA with Kruskal-Wallis H test compared groups (Mac_cl1 as reference). h , i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours. After removing apoptotic cells, RNA was extracted for qPCR. Bar plots show transcript differences between Gpr34 +/+ and Gpr34 −/− BMDMs ( h ) efferocytosis receptors, ( i ) lysosome-related/transcription factors, ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-incubated with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours and analyzed by flow cytometry. Bar plot shows differences in MHC-I protein levels between knockdown and control groups ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. k BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with lysosomal inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Bar plot shows pHrodo gMFI in macrophages from flow cytometry, comparing lysosomal inhibitor group vs control. One-way ANOVA with Dunnett’s test was used . Data are presented by mean ± SD. l , m Flow cytometry detection of macrophage antigen presentation function ( l ) and CD8 + T cell specific killing capacity ( m ) in the BMDM-OT1 CD8 + T cell co-culture system. Bar plots show differences between lysosomal inhibitor and control groups. One-way ANOVA with Dunnett ’ s test was used. Data are presented by mean ± SD. n BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM, MerTK inhibitor/Lysosome inhibitor and chemotherapy-induced apoptotic KPC cells for 12 hours. Bar plot shows differences in MHC-I protein levels between different groups detected by flow cytometry ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. o –q BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, transiently transfected with Cxcl16 siRNA, co-incubated with TCM, LysoPS and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with MerTK inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Flow cytometry detected CD8 + T cell specific killing function (o ), cytotoxic function ( p ), and exhaustion levels ( q ). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Journal: Signal Transduction and Targeted Therapy

    Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer

    doi: 10.1038/s41392-026-02641-4

    Figure Lengend Snippet: Macrophage efferocytosis function influences antigen presentation ability through MHC-I. a BMDMs from C57BL/6 mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 hours, then analyzed by flow cytometry for GFP uptake. Bar plot shows gMFI of GFP in BMDMs treated with MerTK inhibitor vs control ( n = 3). One-way ANOVA with Dunnett’s test compared MerTKi groups to control. Data are presented by mean ± SD. b BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP cells for 12 hours, treated with MerTK inhibitor, then co-cultured with CD8 + T cells from OT1 mice for 24 hours. Flow cytometry detected MHC-I, SIINFEKL loading, CD80, CD86 on BMDMs. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. c Flow cytometry detection of Tetramer + , PD-1 + , Tim-3 + , and GZMB + cells after co-culture of BMDMs with OT1 CD8 + T cells. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. d Apoptotic KPC cells induced by chemotherapy and labeled with Caspase3/7 green were co-cultured with BMDMs. Phagolysosome formation was detected using pHrodo red. Representative fluorescence microscopy images (1000x) show differences between MerTK inhibitor and control groups ( n = 6). Green: Caspase3/7, Red: pHrodo, Blue: DAPI. White scale bar= 20 μm. e Bar plots show total pHrodo fluorescence intensity (left) and the number of Caspase3/7 + pHrodo + vesicles per cell (right) in BMDMs after incubation with apoptotic cells ( n = 6). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. f Flow cytometry analysis of pHrodo gMFI in BMDMs after incubation with apoptotic cells. Bar plot shows pHrodo gMFI levels between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. g Violin-box plots of lysosome-associated gene transcript expression in macrophage subpopulations from scRNA sequencing data. Solid lines represent medians and quartiles. One-way ANOVA with Kruskal-Wallis H test compared groups (Mac_cl1 as reference). h , i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours. After removing apoptotic cells, RNA was extracted for qPCR. Bar plots show transcript differences between Gpr34 +/+ and Gpr34 −/− BMDMs ( h ) efferocytosis receptors, ( i ) lysosome-related/transcription factors, ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-incubated with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours and analyzed by flow cytometry. Bar plot shows differences in MHC-I protein levels between knockdown and control groups ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. k BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with lysosomal inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Bar plot shows pHrodo gMFI in macrophages from flow cytometry, comparing lysosomal inhibitor group vs control. One-way ANOVA with Dunnett’s test was used . Data are presented by mean ± SD. l , m Flow cytometry detection of macrophage antigen presentation function ( l ) and CD8 + T cell specific killing capacity ( m ) in the BMDM-OT1 CD8 + T cell co-culture system. Bar plots show differences between lysosomal inhibitor and control groups. One-way ANOVA with Dunnett ’ s test was used. Data are presented by mean ± SD. n BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM, MerTK inhibitor/Lysosome inhibitor and chemotherapy-induced apoptotic KPC cells for 12 hours. Bar plot shows differences in MHC-I protein levels between different groups detected by flow cytometry ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. o –q BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, transiently transfected with Cxcl16 siRNA, co-incubated with TCM, LysoPS and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with MerTK inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Flow cytometry detected CD8 + T cell specific killing function (o ), cytotoxic function ( p ), and exhaustion levels ( q ). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

    Article Snippet: For antigen-specific assays, BMDMs were pulsed with 1 μg/mL SIINFEKL peptide (MCE, HY-P1489) for 2 hours.

    Techniques: Immunopeptidomics, Cell Culture, Flow Cytometry, Control, Incubation, Co-Culture Assay, Labeling, Fluorescence, Microscopy, Expressing, Sequencing, Two Tailed Test, Transfection, Knockdown